AZN
What one share of Astrazeneca holds
Pharmaceutical Preparations
Astrazeneca’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $37.60 |
|---|---|
| Profit | $6.55 |
| Capex (buildings and equipment) | $1.80 |
| Free cash flow | $7.53 |
| Dividends | $3.13 |
| Cash and investments | $3.68 |
| Debt | $19.11 |
| Book value | $31.40 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $18.17 | $2.76 | $1.14 | $2.13 | — | $11.74 |
| 2017 | $17.73 | $2.37 | $1.05 | $1.78 | — | $11.82 |
| 2018 | $17.43 | $1.70 | $0.82 | $1.24 | — | $9.84 |
| 2019 | $18.74 | $1.03 | $0.75 | $1.53 | — | $10.09 |
| 2020 | $20.27 | $2.44 | $0.73 | $2.92 | $2.80 | $11.91 |
| 2021 | $26.22 | $0.08 | $0.76 | $3.41 | $2.80 | $27.69 |
| 2022 | $28.43 | $2.11 | $0.70 | $5.59 | $2.90 | $23.93 |
| 2023 | $29.33 | $3.81 | $0.87 | $5.75 | $2.90 | $25.27 |
| 2024 | $34.60 | $4.50 | $1.23 | $6.36 | $2.97 | $26.31 |
| 2025 | $37.60 | $6.55 | $1.80 | $7.53 | $3.13 | $31.40 |